DROXIA 6337 (Droxia 400 MG)
Generic Name: hydroxyurea
Pill with imprint DROXIA 6337 is Orange, Capsule-shape and has been identified as Droxia 400 MG. It is supplied by Bristol-Myers Squibb.
Droxia is used in the treatment of anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 400 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for DROXIA 6337
Droxia
- Generic Name:
- hydroxyurea
- Imprint:
- DROXIA 6337
- Strength:
- 400 MG
- Color:
- Orange
- Size:
- 22.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antimetabolites
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
- Inactive Ingredients:
- citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
D&C Red No. 28
D&C Red No. 33
D&C Yellow No. 10
Note: Inactive ingredients may vary.
More about Droxia (hydroxyurea)
- Droxia Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews
- Drug class: antimetabolites
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
